 Connection
Gregory Downey to Cystic Fibrosis Transmembrane Conductance Regulator
This is a "connection" page, showing publications Gregory Downey has written about Cystic Fibrosis Transmembrane Conductance Regulator.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.622 |
|
|
|
-
Vij N, Downey GP. The yin and yang of cystic fibrosis transmembrane conductance regulator function: implications for chronic lung disease. Am J Respir Crit Care Med. 2013 Jan 15; 187(2):120-2.
Score: 0.354
-
Ramsey BW, Downey GP, Goss CH. Update in Cystic Fibrosis 2018. Am J Respir Crit Care Med. 2019 05 15; 199(10):1188-1194.
Score: 0.137
-
Vandivier RW, Richens TR, Horstmann SA, deCathelineau AM, Ghosh M, Reynolds SD, Xiao YQ, Riches DW, Plumb J, Vachon E, Downey GP, Henson PM. Dysfunctional cystic fibrosis transmembrane conductance regulator inhibits phagocytosis of apoptotic cells with proinflammatory consequences. Am J Physiol Lung Cell Mol Physiol. 2009 Oct; 297(4):L677-86.
Score: 0.070
-
Koehler DR, Downey GP, Sweezey NB, Tanswell AK, Hu J. Lung inflammation as a therapeutic target in cystic fibrosis. Am J Respir Cell Mol Biol. 2004 Oct; 31(4):377-81.
Score: 0.050
-
Gilljam M, Moltyaner Y, Downey GP, Devlin R, Durie P, Cantin AM, Zielenski J, Tullis DE. Airway inflammation and infection in congenital bilateral absence of the vas deferens. Am J Respir Crit Care Med. 2004 Jan 15; 169(2):174-9.
Score: 0.012
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|